Ask AI
ProCE Banner Series

Empowering Collaboration in R/R MM: Amplifying the Patient's Voice to Equip Community HCPs With Practical Strategies for Optimizing Bispecific Antibody Therapy

Join us for an expert-led workshop series on managing relapsed/refractory multiple myeloma using bispecific antibodies, with topics including considerations for selecting and administering bispecific antibodies, adverse event monitoring and management, and partnerships between academic and community cancer centers to optimize patient care.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity’s target audience includes community hematologists/oncologists, nurses, pharmacists, physician associates and other healthcare professionals responsible for the care and treatment of patients with relapsed/refractory multiple myeloma.

Topics

Multiple myeloma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, competence, and performance in caring for MM patients receiving BCMA BsAbs.

Target Audience
This activity’s target audience includes community hematologists/oncologists, nurses, pharmacists, physician associates and other healthcare professionals responsible for the care and treatment of patients with relapsed/refractory multiple myeloma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Analyze the criteria for R/R MM diagnosis and the subsequent process for timely initiation of care, emphasizing the importance of early intervention

  • Demonstrate proficiency in the handling, administration, and transitioning care of BsAbs from academic to community settings, ensuring continuity of care

  • Evaluate the available clinical data on BCMA BsAbs, interpreting insights into their efficacy, appropriate dosing, and adverse events (AEs) profiles for informed decision-making

  • Identify the key risk factors associated with treatment-specific AEs related to BsAbs and formulate evidence-based strategies for timely identification and effective management

  • Advocate for equity in R/R MM treatment by recognizing disparities in care, highlighting experiences with BsAbs, and promoting strategies that ensure equitable access to treatment for diverse and underrepresented patient populations

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191